French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and weight control drug semaglutide to just once a month, according to new ...
We conducted the BedMed trial in the general primary-care population and the BedMed-Frail trial in nursing-home residents and while evening dosing was safe, it conveyed no additional advantages." ...